- 2-(3-(2-(DIETHYLAMINO)ETHYLAMINO)-PROPYL)-2-METHYL-1,3-BENZODIOXOLE DIMALEATE
- 2-(3-(2-(DIETHYLAMINO)ETHYLAMINO)-PROPYL)-2-METHYL-1,3-NAPHTHOL(2,3-d)DIOXOLE DIHYDROCHLORIDE
- 2-(3-(2-CHLOROETHYL)3-NITROSOUREIDO) ETHYL METHANE SULFONATE
- 2-(3-(4-HYDROXY-4-p-CHLOROPHENYL-PIPERIDINO)-PROPYL)-3-METHYL-7-FLUOROCHROMONE
- 2-(3-(N-ETHYLACETAMIDO)-2,4,6-TRIIODO-PHENYL)BUTYRIC ACID
- 2-(3-(N-PHENYLPIPERAZINO)-PROPYL)-3-METHYL-7-FLUOROCHROMONE
- 2-(3-(N-PHENYLPIPERAZINO)-PROPYL)-3-METHYLCHROMONE
- 2-(3-(p-Fluorobenzoyl)-1-propyl)-5-alpha,9-alpha-dimethyl-2'-hydroxy-6,7-benzomorphan
- 2-(3-(Pyridin-2-yl)pyrrolidin-3-yl)ethanol
- 2-(3, 4-Dihydroxyphenyl-d3)ethylamine HCl
- 3598-37-6ACEPROMAZINE MALEATE
- 359842-08-31,3,5,7-Tetraazatricyclo[3.3.1.13,7]decan-2-ol
- 359849-58-4Cyclopentanecarboxylicacid, 2-amino-, hydrochloride (1:1), (1S,2S)-
- 3598-66-1Benzene,1,3-dichloro-2-(2-propyn-1-yloxy)-
- 359866-37-82-(2-methoxypropan-2-yl)pyrrolidin-1-amine
- 359877-97-7Benzenemethanamine, 3-bromo-, hydrobromide(1:1)
- 359880-05-04-Piperidinone,1-cyclobutyl-
- 35988-42-2Kaur-16-ene-18,19-dioicacid, 15-hydroxy-2-[[2-O-(3-methyl-1-oxobutyl)-3,4-di-O-sulfo-a-D-glucopyranosyl]oxy]-, (2b,15a)-
- 359-88-6Propanoic acid,3,3,3-trifluoro-2-(methoxymethyl)-, methyl ester
- 35989-16-3Glutamic acid,N-methyl-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
2-(3,3-Dimethylallyl)cyclazocine |
EINECS | 206-634-6 |
| CAS No. | 359-83-1 | Density | 1.036g/cm3 |
| PSA | 23.47000 | LogP | 3.82050 |
| Solubility | N/A | Melting Point |
145.4-147.20ºC |
| Formula | C19H27 N O | Boiling Point | 403.5°C at 760 mmHg |
| Molecular Weight | 285.429 | Flash Point | 180.8°C |
| Transport Information | N/A | Appearance | Crystalline Solid |
| Safety | Poison by ingestion, subcutaneous, intramuscular, intraperitoneal, and intravenous routes. Experimental reproductive effects. Human systemic effects by intramuscular and intravenous routes: wakefulness, euphoria, hallucinations or distorted perceptions, tremors, convulsions, excitement, motor activity changes, muscle weakness, analgesia, withdrawal, parasympathomimetic effects, nausea or vomiting, and dermititis. Can cause drug dependency and other central nervous system effects. An analgesic. When heated to decomposition it emits toxic fumes of NOx. See also ALLYL COMPOUNDS. | Risk Codes | 22 |
| Molecular Structure |
|
Hazard Symbols |
 Xn
|
| Synonyms |
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2R,6R,11R)-rel-(9CI); 2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2a,6a,11R*)- (8CI); (?à)-Pentazocine;1,2,3,4,5,6-Hexahydro-3-(3-methyl-2-butenyl)-6,11-dimethyl-8-hydroxy-2,6-methano-3-benzazocine;1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol;2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan;2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan; 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-8-hydroxy-6,11-dimethyl-2,6-methano-3-benzazocine;Fortalgesic; Fortalin; Fortral; Fortwin; II-C 2; Lexir; NIH 7958; Peltazon;Pentagin; Pentazocin; Pentazocine; Sosegon; Soseton; Sosigon; Talwin; Win20228; cis-(?à)-Pentazocine;dl-Pentazocine |
Article Data | 10 |
2-(3,3-Dimethylallyl)cyclazocine Chemical Properties
Product Name: 2-(3,3-Dimethylallyl)cyclazocine
The MF of 2-(3,3-Dimethylallyl)cyclazocine (CAS NO.359-83-1) is C19H27NO.
The MW of 2-(3,3-Dimethylallyl)cyclazocine (CAS NO.359-83-1) is 285.42.
Synonyms of 2-(3,3-Dimethylallyl)cyclazocine (CAS NO.359-83-1): (1R,9R,13R)-1,13-Dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol ; 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan ; Fortalin
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals;Agonists;Opioids;Pharmacologicals
Apperance: Crystalline Solid
Index of Refraction: 1.553
EINECS: 206-634-6
Density: 1.036 g/ml
Flash Point: 180.8 °C
Boiling Point: 403.5 °C
Melting Point: 145-147 °C
2-(3,3-Dimethylallyl)cyclazocine Uses
2-(3,3-Dimethylallyl)cyclazocine (CAS NO.359-83-1) is used as mixed opioid agonist-antagonist,controlled substance and analgesic (narcotic).
2-(3,3-Dimethylallyl)cyclazocine Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| human | LDLo | oral | 18mg/kg (18mg/kg) | LUNGS, THORAX, OR RESPIRATION: BRONCHIECTASIS | Clinical Toxicology. Vol. 10, Pg. 327, 1977. |
| human | TDLo | intramuscular | 571ug/kg (0.571mg/kg) | BEHAVIORAL: EUPHORIA GASTROINTESTINAL: NAUSEA OR VOMITING BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Journal of Pharmacology and Experimental Therapeutics. Vol. 143, Pg. 149, 1964. |
| human | TDLo | intravenous | 300mg/kg/D (300mg/kg) | BEHAVIORAL: ANALGESIA BEHAVIORAL: WITHDRAWAL | British Medical Journal. Vol. 2, Pg. 21, 1978. |
| mammal (species unspecified) | LD50 | intraperitoneal | 140mg/kg (140mg/kg) | United States Patent Document. Vol. #4205173, | |
| man | TDLo | intramuscular | 83mg/kg/4Y-I (83mg/kg) | MUSCULOSKELETAL: JOINTS | Archives of Internal Medicine. Vol. 143, Pg. 2203, 1983. |
| man | TDLo | intravenous | 3mg/kg/2D-I (3mg/kg) | BEHAVIORAL: WAKEFULNESS BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" BEHAVIORAL: EXCITEMENT | Journal of Pharmacology and Experimental Therapeutics. Vol. 143, Pg. 149, 1964. |
| mouse | LD50 | intramuscular | 98mg/kg (98mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 190, Pg. 124, 1971. |
| mouse | LD50 | intraperitoneal | 85mg/kg (85mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ANALGESIA BEHAVIORAL: ATAXIA | Chemical and Pharmaceutical Bulletin. Vol. 24, Pg. 2912, 1976. |
| mouse | LD50 | intravenous | 19800ug/kg (19.8mg/kg) | Drugs in Japan Vol. 6, Pg. 777, 1982. | |
| mouse | LD50 | oral | 305mg/kg (305mg/kg) | Acta Medicia Okayama. Vol. 35, Pg. 179, 1981. | |
| mouse | LD50 | subcutaneous | 140mg/kg (140mg/kg) | Acta Medicia Okayama. Vol. 35, Pg. 179, 1981. | |
| rat | LD50 | intramuscular | 175mg/kg (175mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 190, Pg. 124, 1971. |
| rat | LD50 | intravenous | 21mg/kg (21mg/kg) | "Synthetic Analgesics," Oxford, Pergamon Press, 1966Vol. 2, Pg. 174, 1966. | |
| rat | LD50 | oral | 1110mg/kg (1110mg/kg) | AUTONOMIC NERVOUS SYSTEM: OTHER (DIRECT) PARASYMPATHOMIMETIC BEHAVIORAL: TREMOR BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Kiso to Rinsho. Clinical Report. Vol. 4, Pg. 2145, 1970. |
| rat | LD50 | subcutaneous | 165mg/kg (165mg/kg) | Acta Medicia Okayama. Vol. 35, Pg. 179, 1981. | |
| rat | LD50 | unreported | 280mg/kg (280mg/kg) | BEHAVIORAL: ANALGESIA | Pharmacological Research Communications. Vol. 5, Pg. 175, 1973. |
| women | TDLo | intramuscular | 1400mg/kg/3Y (1400mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) BEHAVIORAL: MUSCLE WEAKNESS SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | JAMA, Journal of the American Medical Association. Vol. 231, Pg. 271, 1975. |
2-(3,3-Dimethylallyl)cyclazocine Safety Profile
Poison by ingestion, subcutaneous, intramuscular, intraperitoneal, and intravenous routes. Experimental reproductive effects. Human systemic effects by intramuscular and intravenous routes: wakefulness, euphoria, hallucinations or distorted perceptions, tremors, convulsions, excitement, motor activity changes, muscle weakness, analgesia, withdrawal, parasympathomimetic effects, nausea or vomiting, and dermititis. Can cause drug dependency and other central nervous system effects. An analgesic. When heated to decomposition it emits toxic fumes of NOx. See also ALLYL COMPOUNDS.Safety information of 2-(3,3-Dimethylallyl)cyclazocine (CAS NO.359-83-1):
Hazard Codes 
Xn
Risk Statements
R22:Harmful if swallowed.
RTECS PB8750000
What can I do for you?
Get Best Price
